EP1644397 - Bibliographic data
SPECIFIC GLUCOCORTICOSTEROID COMPOUND HAVING ANTI- INFLAMMATORY ACTIVITY
| Last update | 12/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
GLAXO GROUP LIMITED 980 Great West Road
Brentford, Middlesex TW8 9GS
Royaume-Uni
|
|---|---|
| (72) Inventors |
BIGGADIKE, Keith GlaxoSmithKline Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY
Royaume-Uni
NEEDHAM, Deborah GlaxoSmithKline Gunnels Wood Road
Stevenage Hertfordshire SG1 2NY
Royaume-Uni
|
| (74) Agent |
Mail recipient Cabinet José CURAU 17, rue Basse
98000
MONACO
Principauté de Monaco
|
| (21) Request number | EP04741020.4 |
|---|---|
| (22) Request date | 09/07/2004 |
| (11) Publication number | EP1644397 |
|---|---|
| Publication date | 12/05/2010 |
| (54) Title of the invention | SPECIFIC GLUCOCORTICOSTEROID COMPOUND HAVING ANTI- INFLAMMATORY ACTIVITY |
|---|---|
| (51) International classification | C07J 3/00, A61K 31/56, A61P 5/44 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 0316290 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 19 -
Amount: 400 € -
Due date 01/08/2022
Surtax: 19 - Amount: 80 € - Due date 02/02/2023 |
|---|---|
| Last annuity | Annuity: 18 - Payment date 28/06/2021 |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2010/2, of 30/06/2010 CHANGEMENT D'ADRESSE - bulletin 2013/2, of 30/06/2013 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 12/05/2010 Entrée en période de grâce du brevet d'invention - Legal date 02/08/2022 Génération de l'avertissement avant déchéance - Legal date 10/08/2022 Déchéance du brevet d'invention après période de grâce - Legal date 01/08/2022 |